CASP1 and steatosis: Some studies have found that Caspase-1 is associated with steatosis, and treatment with the Caspase-1 inhibitor VX765 in mice with alcohol-induced liver injury results in reduced hepatic lipid deposition and lower serum TG levels, which in turn decreases liver injury [56].